Insights from 2023 ESMO Annual Meeting


 

ESMO 2023 Insights: "OS in Patients With Metastatic BRAF V600-Mutant Melanoma Treated With Encorafenib + Binimetinib: Real-World vs. Clinical Trial Data"

73 views
November 24, 2023
Comments 0
Login to view comments. Click here to Login